Search

Contemporary Considerations in Multiple Sclerosis Treatment: A Post-Pandemic Educational Curriculum MedPoints™ in Multiple Sclerosis

This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education.

This activity is supported by independent educational grants from
Biogen and Bristol Myers Squibb.

Target Audience

MS specialists, general neurologists, nursing professionals, pharmacists, PAs, and patient advocates in the care of people living with multiple sclerosis (MS).

Faculty

Robert K. Shin, MD, FANA, FAAN
Professor, Department of Neurology
MedStar Georgetown University Hospital
Washington, DC

Accreditation

In support of improving patient care, this activity has been planned and implemented by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.

Credits available for Physicians, Pharmacists and Nursing Professionals

MedPointsTM in Multiple Sclerosis Initial Therapy

Learning Objectives
At the conclusion of this activity, participants should be better able to:

  • Discuss evidence-based treatment decision-making related to early treatment initiation and its impact on patient outcomes
  • Review key efficacy and safety data for available disease-modifying therapies (DMTs) when making early treatment decisions
  • Utilize treatment- and patient-specific considerations, along with patient preferences, in making initial and subsequent therapy decisions

Release date: March 3, 2023
Expiration date: March 3, 2024
The estimated time to complete the activity is 30 minutes.

MedPointsTM in Multiple Sclerosis Patient Perspectives

Learning Objectives
At the conclusion of this activity, participants should be better able to:

  • Utilize treatment- and patient-specific considerations, along with patient preferences, in making initial and subsequent therapy decisions

Release date: March 3, 2023
Expiration date: March 3, 2024
The estimated time to complete the activity is 30 minutes.

MedPointsTM in Multiple Sclerosis DMTs and the Immune System

Learning Objectives
At the conclusion of this activity, participants should be better able to:

  • Examine the mechanisms of action of disease-modifying therapies (DMTs) and the clinical implications of their effects on the immune system

Release date: March 30, 2023
Expiration date: March 30, 2024
The estimated time to complete the activity is 30 minutes.

MedPointsTM in Multiple Sclerosis DMTs and COVID-19

Learning Objectives
At the conclusion of this activity, participants should be better able to:

  • Review evidence and recommendations related to DMTs and vaccine response, including to COVID-19 vaccines, in people with MS

Release date: March 30, 2023
Expiration date: March 30, 2024
The estimated time to complete the activity is 30 minutes.

About Me

The Continuing Medical Education Program is an integral part of the organization’s overall mission which aims to improve learners’ competence and performance‐in‐practice and ultimately improve patient outcomes.

Related Posts